"Is it a subscription?" No
By recognizing that obesity is a complex, chronic disease and not a lifestyle choice or a matter of willpower, we can help people find an integrated and personalized treatment approach that promotes long-term health and well-being, Neff adds
Insurance companies are probably paying ~$3-5K/year (after deductible usage) for these medications, and pharma is receiving anywhere from 40-70% of the list
These drugs work by mimicking the action of naturally occurring GLP-1, an incretin hormone that stimulates insulin secretion in response to food intake, suppresses glucagon release, and slows gastric emptying
Side effects: Nausea, constipation, and occasional vomiting similar to existing GLP-1 therapies
Lipedema is associated with increased aortic stiffness